Fluid Synchrony, based in Pasadena, United States, specializes in advanced microinfusion technology designed to provide precise, controlled, and personalized drug delivery. Their patented microtechnologies enable the safe and localized delivery of various liquid drug formulations directly to diseased tissue. The system supports wireless control, on-demand programming, and remote monitoring, allowing for evidence-based and personalized drug therapy. Fluid Synchrony’s solutions are ideal for chronic treatments and are applicable across a wide range of animal models.
Fluid Synchrony has made significant strides in the field of microinfusion technology, offering a miniaturized pump system that enhances dosing flexibility and safety. Their programmable electronic dosing control simplifies complex dosing regimens, making it easier for researchers and medical professionals to manage chronic treatments. The company's innovative use of MEMS (Micro-Electro-Mechanical Systems) technology has positioned them as a leader in the market for precise drug delivery systems, contributing to more effective and personalized medical treatments.